Insider Transactions in Q1 2022 at Igm Biosciences, Inc. (IGMS)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2022
|
M Kathleen Behrens |
BUY
Grant, award, or other acquisition
|
Direct |
374
+12.38%
|
-
|
|
Mar 31
2022
|
Michael D Loberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
533
+50.0%
|
-
|
|
Mar 31
2022
|
Christina Teng Topsoe |
BUY
Grant, award, or other acquisition
|
Direct |
346
+0.93%
|
-
|
|
Mar 31
2022
|
Jakob Haldor Topsoe |
BUY
Grant, award, or other acquisition
|
Direct |
230
+0.41%
|
-
|
|
Mar 31
2022
|
Michael Stewart Lee Director |
BUY
Grant, award, or other acquisition
|
Direct |
230
+13.59%
|
-
|
|
Mar 31
2022
|
Redmile Group, LLC Director |
BUY
Grant, award, or other acquisition
|
Indirect |
230
+0.01%
|
-
|
|
Mar 30
2022
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
7,500
-15.78%
|
$210,000
$28.5 P/Share
|
|
Mar 30
2022
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+13.63%
|
$0
$0.93 P/Share
|
|
Mar 15
2022
|
Lisa Lynn Decker CHIEF BUSINESS OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
4,617
+17.04%
|
-
|
|
Mar 15
2022
|
George Gauthier Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,096
+23.63%
|
-
|
|
Mar 15
2022
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
14,319
+26.35%
|
-
|
|
Mar 15
2022
|
Fred Schwarzer CEO AND PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
23,002
+39.7%
|
-
|
|
Mar 15
2022
|
Misbah Tahir CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
6,084
+15.08%
|
-
|
|
Mar 15
2022
|
Chris H Takimoto CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
14,477
+28.14%
|
-
|
|
Mar 12
2022
|
Lisa Lynn Decker CHIEF BUSINESS OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
7,500
+29.57%
|
-
|
|
Mar 12
2022
|
George Gauthier Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,500
+29.33%
|
-
|
|
Mar 12
2022
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+32.73%
|
-
|
|
Mar 12
2022
|
Misbah Tahir CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+30.73%
|
-
|
|
Mar 12
2022
|
Chris H Takimoto CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+35.71%
|
-
|
|
Feb 08
2022
|
Michael D Loberg Director |
BUY
Bona fide gift
|
Indirect |
300
+33.33%
|
-
|
|
Feb 08
2022
|
Michael D Loberg Director |
SELL
Bona fide gift
|
Direct |
300
-100.0%
|
-
|